1. Ajani, JA, Ilson, D, Daugherty, K, Pazdur, R & Kelsen, DP (1994). Taxol (Paclitaxel) is active against carcinoma of the esophagus: report of Phase II trial. Proc Am Soc Clin Oncol 13: 192.
2. Akutsu, M, Kano, Y, Tsunoda, S, Suzuki, K, Yazawa, Y & Miura, Y (1995). Schedule-dependent interaction between paclitaxel and doxorubicin in human cancer cell lines in vitro. Eur J Cancer 31A: 2341–2346.
3. Anonymous (1997). Paclitaxel and docetaxel in breast and ovarian cancer. Drug Ther Bull 35: 43–46.
4. Belani, CP (1998). Paclitaxel/carboplatin in the treatment of non-small-cell lung cancer. Oncology 12: 74–79.
5. Catherine, MW, Jian, Z, Patricia, A, McQueney, DB & Elias, L (1995). Paclitaxel-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol Med 1: 506–526.